Crossref
International Reference Pricing in Congressional Bill H.R.3 and Its Potential Impact on the U.S. Biotech Ecosystem
Medicine and Clinical Science · 2020
DOI: 10.33425/2690-5191.1028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medicine and Clinical Science, 2020. Verfasst von Duane Schulthess. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Schulthess, D. (2020). International Reference Pricing in Congressional Bill H.R.3 and Its Potential Impact on the U.S. Biotech Ecosystem. Medicine and Clinical Science. https://doi.org/10.33425/2690-5191.1028
Vancouver
Schulthess D. International Reference Pricing in Congressional Bill H.R.3 and Its Potential Impact on the U.S. Biotech Ecosystem. Medicine and Clinical Science. 2020. doi:10.33425/2690-5191.1028
BibTeX
@article{Schulthess2020,
author = {Schulthess, Duane},
title = {International Reference Pricing in Congressional Bill H.R.3 and Its Potential Impact on the U.S. Biotech Ecosystem},
journal = {Medicine and Clinical Science},
year = {2020},
doi = {10.33425/2690-5191.1028}
}
EUVIMED